Is NeuroPace Inc (NPCE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 15.7% / 30% | 11.3% / 30% | 2.8% / 30% | 3.78% / 5% | ✓ HALAL |
| DJIM | 15.7% / 33% | 11.3% / 33% | 2.8% / 33% | 3.78% / 5% | ✓ HALAL |
| MSCI | 77.5% / 33% | 55.7% / 33% | 13.6% / 33% | 3.78% / 5% | ✗ NOT HALAL |
| S&P | 15.7% / 33% | 11.3% / 33% | 2.8% / 33% | 3.78% / 5% | ✓ HALAL |
| FTSE | 77.5% / 33% | 55.7% / 33% | 13.6% / 50% | 3.78% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 77.2% | |
| Operating Margin | -6.6% | |
| Net Margin | -21.5% | |
| Return on Equity (ROE) | -158.7% | |
| Return on Assets (ROA) | -10.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$11M |
| Free Cash Flow | -$11M |
| Total Debt | $71M |
| Debt-to-Equity | 372.2 |
| Current Ratio | 5.3 |
| Total Assets | $106M |
Price & Trading
| Last Close | $13.66 |
| 50-Day MA | $14.83 |
| 200-Day MA | $12.45 |
| Avg Volume | 214K |
| Beta | 1.9 |
|
52-Week Range
$7.56
| |
About NeuroPace Inc (NPCE)
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Purification Calculator
As a halal stock with 3.78% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is NeuroPace Inc (NPCE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), NeuroPace Inc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is NeuroPace Inc's debt ratio?
NeuroPace Inc's debt ratio is 15.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 77.5%.
Does NeuroPace Inc require dividend purification?
Yes, NeuroPace Inc has an impermissible income ratio of 3.78%, which means 3.78% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are NeuroPace Inc's key financial metrics?
NeuroPace Inc has a market capitalization of $449M, and revenue of $100M. The company maintains a gross margin of 77.2% and a net margin of -21.5%. Return on equity stands at -158.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.